OTC · Medical - Devices

Imagin Medical Inc. (IMEXF) Stock

$0.00 OTC: IMEXF Healthcare

Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It has a license agreement with Lawrence Livermore National Security, LLC to develop, manufacture, and sell a medical imaging device.

Valuation

MetricValue
Price$0.00
Market Cap$1083
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-0.06
52-Week High$0.01
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE15.38%
ROA-191.49%
ROCE25.51%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-1.00
Current Ratio0.01

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$0
Operating Profit$-8.0M$-4.0M$-4.0M$-3.0M$-3.0M
Net Profit$-8.0M$-4.0M$-4.0M$-11.0M$-2.0M
EPS$-1.48$-0.64$-0.53$-1.27$-0.25
Op Margin—————

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$6.0M$2.0M$0$1.0M$1.0M
Total Liabilities$0$0$1.0M$12.0M$15.0M
Cash$6.0M$2.0M$0$0$0
Borrowings$0$0$0$12.0M$13.0M

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-5.0M$-4.0M$-4.0M$-4.0M$-3.0M
Investing Cash Flow$0$0$0$0$-2.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$6.0M$-4.0M$-2.0M$0$0
Free Cash Flow$-5.0M$-4.0M$-4.0M$-4.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-3.94
FCF Yield-223133.56%
Quick Ratio0.01
Interest Coverage-434.26
Return 1Y0.00%
Return 3Y-99.85%
Return 5Y—

Ownership

Insiders Held11.27%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Imagin Medical Inc.

Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It has a license agreement with Lawrence Livermore National Security, LLC to develop, manufacture, and sell a medical imaging device. The company is headquartered in Vancouver, Canada.

Imagin Medical Inc. (IMEXF) stock trades at $0.00 with a market capitalization of $1083. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, Imagin Medical Inc. generates a return on equity (ROE) of 15.38%, above the typical market average, return on capital employed of 25.51%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.imaginmedical.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides